Tuberculosis: Current situation, Challenge and Overview of its control programme in India

Registration ID: IJNRD_218021

Published ID: IJNRD2404321

DOI: Click Here to Get

Vishakha Limkar , Srusthi Mahanaver , Dipti Baraskar , Sanika Shingnapure , DR. Aamer Quazi

DOTS, MDR-TB(Multidrug-Resistant Tuberculosis), RNTCP (Revsed national TB control programe), STOP TB strategy, WHO (world health organzation), HIV.

Tuberculosis (TB) is one of humanities oldest disease, with molecular evidence dating back to more than 17,000 years. Tuberculosis (TB) remains one of the deadliest infectious diseases, causing millions of deaths worldwide each year. In this article, we provide an overview of tuberculosis, including pathogenesis, diagnosis, and treatment guidelines. Tuberculosis (TB) remains one of the deadliest infectious diseases, causing millions of deaths worldwide each year. In this article, we provide an overview of tuberculosis, including pathogenesis, diagnosis, and treatment guidelines. Despite newer methods to diagnose and treat tuberculosis, unfortunately people still suffer and it is among the 10 deadliest infectious diseases in the world, second only to HIV. According to the World Health Organization (WHO), tuberculosis is a global pandemic. It is the leading cause of death in people infected with HIV. Historically, India's fight against tuberculosis can be classified in three periods: the initial phase, before the discoveries of X-ray and chemotherapy; the post-independence period when national tuberculosis control programs were initiated and implemented; and the current period during which the ongoing TB control program continues. Today, India's DOTS (Directly Observed Short Course of Treatment) program is the fastest growing and largest program in the world in terms of the number of patients initiated. and the second largest population coverage. Major challenges to TB control in India include poor primary health care infrastructure in rural areas of many states; unregulated private healthcare leading to widespread irrational use of first- and second-line TB drugs; spread of HIV infection; lack of political will; and above all corrupt administration. Multidrug-resistant tuberculosis (MDR-TB) is another emerging threat to TB eradication and is caused by inadequate or deteriorating TB control programs. Through its "STOP TB" strategy, WHO has set a vision to eliminate tuberculosis as a public health problem from this earth by 2050. The information in this review article is available on the official WHO website; Ministry of Health and Government of India were consulted and PubMed® Google Scholar® search engines were used.

Published Paper   E-Certificate

Vishakha Limkar, Srusthi Mahanaver, Dipti Baraskar, Sanika Shingnapure, & DR. Aamer Quazi (April-2024). Tuberculosis: Current situation, Challenge and Overview of its control programme in India. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(4), d166-d170. https://ijnrd.org/papers/IJNRD2404321.pdf

Volume 9 Issue 4, April-2024

Pages : d166-d170

Paper Reg. ID: IJNRD_218021

Published Paper Id: IJNRD2404321

Downloads: 000121981

Research Area: Science

Country: Osmanabad, Maharastra, India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2404321.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2404321

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 10 | October 2025

IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.

Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

Important Dates for Current issue

Paper Submission Open For: October 2025

Current Issue: Volume 10 | Issue 10 | October 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 31-Oct-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details